Andrew R. Adams
Mairs & Power Growth Fund
Mairs & Power Growth Fund Medpace Holdings Inc stake
total: 96
Mairs & Power Growth Fund MEDP trades
- Total transactions:
- 3
- New positions:
- 1
- Added:
- 2
- Held since:
- 2025 Q2
- Held for:
- 5 quarters
- Latest activity:
- 2026 Q1
According to 2026 Q2 report, Mairs & Power Growth Fund holds 61,028 Medpace Holdings Inc (MEDP) shares with a market value of roughly $32.32M accounting for 0.58% of the overall portfolio. To date, the estimated cost basis is nearly $360.33 for "buy" trades. Mairs & Power Growth Fund first purchased MEDP in 2025 Q2, initially acquiring 45,000 shares. Since the initial investment in Medpace Holdings Inc (MEDP), Mairs & Power Growth Fund has made 2 more transactions.
When did Mairs & Power Growth Fund buy Medpace Holdings Inc (MEDP)?
Mairs & Power Growth Fund first invested in Medpace Holdings Inc (MEDP) in 2025 Q2 at the reported quarter-end price of $313.86 per share.
What's the cost basis of Mairs & Power Growth Fund's MEDP stake?
The estimated cost basis for Medpace Holdings Inc (MEDP) stake is around $360.33 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $360.33
Mairs & Power Growth Fund's historical trades in Medpace Holdings Inc
3 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
0.58%
|
61,028
|
$480.19
|
$29,305,035
|
+22.06% (+11,028)
|
+0.11%
|
|
2025 Q3
|
0.45%
|
50,000
|
$514.16
|
$25,708,000
|
+11.11% (+5,000)
|
+0.05%
|
|
2025 Q2
|
0.26%
|
45,000
|
$313.86
|
$14,123,700
|
new
|
+0.26%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.